Key statistics
On Friday, Kuros Biosciences AG (0RHR:LSE) closed at 25.38, -25.54% below its 52-week high of 34.08, set on Oct 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 25.38 |
| Low | 25.38 |
| Bid | -- |
| Offer | -- |
| Previous close | 25.40 |
| Average volume | 14.58k |
|---|---|
| Shares outstanding | 39.18m |
| Free float | 28.27m |
| P/E (TTM) | -- |
| Market cap | 989.15m CHF |
| EPS (TTM) | -0.1234 CHF |
Data delayed at least 20 minutes, as of Feb 06 2026 17:22 GMT.
More ▼
Announcements
- Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
- Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
- Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
- Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
- Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
- Kuros statement on media inquiry concerning former Board member
- Kuros Biosciences announces changes in the Board of Directors
- Kuros Biosciences Reports First Half of 2025 Results
- Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance
- Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
More ▼
